Meet Baylee & Jeremiah, two families facing mitochondrial disease.
“Early on, we knew something was wrong,” said Jody Thompson. At only 9 months old, her daughter Baylee was diagnosed with mitochondrial disease.
After months of searching for answers for the weakness in her then seven-month-old son, Jeremiah, his mother Aneesa got a dreaded answer.
Mitochondrial Disease Research Funding
Results from UMDF Advocacy
0
M+
UMDF-Funded Research
0
M+
National Institutes of Health
0
M+
Department of Defense
Our Impact
Backed by the United Mitochondrial Disease Foundation, the country’s largest research, education, advocacy and support organization for patients with mitochondrial disease, the Mito Fund will ease suffering by funding cutting-edge science and innovation at a new scale.
“Most of the pharmaceutical breakthroughs come from smaller companies. We have to put hundreds of seedlings out there, in hopes that one might blossom into a tree. In UMDF, you have a group of people who create a natural funnel for these ideas to come through. It’s the perfect vehicle to really drill down and find quality projects.”
Dan Wright Founding Donor, The Mito Fund 
"When it comes to this idea of finding partners who would have our same motivation coupled with a financial interest, it just made sense to me. I like the thought of pushing the minds of science with meaningful financial resources to plow ahead and eradicate this disease."
William KallaosFounding Donor, The Mito Fund 
“When it comes to advancing research and charting a course toward a cure, we know our responsibility is to reduce the time to success OR failure. We learn from what doesn’t work, and we apply it to our next investment. We have to find clinically meaningful solutions, and we have to find them now. Our patients can’t wait.”
Brian HarmanUMDF President & CEO 
“Eradicating Mitochondrial Disease is a long way off, but making a meaningful difference in the lives of those currently living with it, and future generations affected by it, honors the legacy of my daughter and the many others who succumbed to mitochondrial disease.”
Philip Yeske, PhD UMDF Science & Alliance Officer 
Previous
Next